[
  {
    "ts": null,
    "headline": "Will ISRG's R&D Focus Following Solid Earnings Growth Drive Demand?",
    "summary": "Intuitive Surgical balances 22% EPS growth with heavier 2026 R&D and expansion spending, betting near-term margin pressure will fuel long-term demand.",
    "url": "https://finnhub.io/api/news?id=356837e3fa7e8d6b11b6d817ce0c9941b7d5d70aa79ae548e7ad68e8216d0ed1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770993480,
      "headline": "Will ISRG's R&D Focus Following Solid Earnings Growth Drive Demand?",
      "id": 139085105,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Intuitive Surgical balances 22% EPS growth with heavier 2026 R&D and expansion spending, betting near-term margin pressure will fuel long-term demand.",
      "url": "https://finnhub.io/api/news?id=356837e3fa7e8d6b11b6d817ce0c9941b7d5d70aa79ae548e7ad68e8216d0ed1"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Corp (NYSE:BSX) Emerges as a Prime GARP Candidate",
    "summary": "Boston Scientific (BSX) exemplifies Growth at a Reasonable Price (GARP) with strong earnings growth, solid profitability, and a sensible valuation within its sector.",
    "url": "https://finnhub.io/api/news?id=4469e830cf0aab3621d9c608639428091373709cb0722d492dab14fb133f2e05",
    "source": "ChartMill",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770988298,
      "headline": "Boston Scientific Corp (NYSE:BSX) Emerges as a Prime GARP Candidate",
      "id": 139080353,
      "image": "https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp",
      "related": "BSX",
      "source": "ChartMill",
      "summary": "Boston Scientific (BSX) exemplifies Growth at a Reasonable Price (GARP) with strong earnings growth, solid profitability, and a sensible valuation within its sector.",
      "url": "https://finnhub.io/api/news?id=4469e830cf0aab3621d9c608639428091373709cb0722d492dab14fb133f2e05"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific to participate in TD Cowen's 46th Annual Health Care Conference",
    "summary": "Boston Scientific Corporation (NYSE: BSX) will participate in TD Cowen's 46th Annual Health Care Conference on Tuesday, March 3, 2026. Mike Mahoney, chairman and chief executive officer, and Kenneth Stein, M.D., senior vice president and global chief medical officer, will participate in a 30-minute question-and-answer session with the host analyst at approximately 9:10 a.m. ET.",
    "url": "https://finnhub.io/api/news?id=dfd39cb4a2a3e981f39af9b77b51203e344025014f30137d8ea77b2dd80883dd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770987600,
      "headline": "Boston Scientific to participate in TD Cowen's 46th Annual Health Care Conference",
      "id": 139081256,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific Corporation (NYSE: BSX) will participate in TD Cowen's 46th Annual Health Care Conference on Tuesday, March 3, 2026. Mike Mahoney, chairman and chief executive officer, and Kenneth Stein, M.D., senior vice president and global chief medical officer, will participate in a 30-minute question-and-answer session with the host analyst at approximately 9:10 a.m. ET.",
      "url": "https://finnhub.io/api/news?id=dfd39cb4a2a3e981f39af9b77b51203e344025014f30137d8ea77b2dd80883dd"
    }
  },
  {
    "ts": null,
    "headline": "BSX Posts Q4 Earnings: Should You Buy, Sell or Hold the Stock?",
    "summary": "Boston Scientific tops Q4 estimates, but shares sink on supply woes and EP losses. Can strong growth drivers fuel a 2026 rebound?",
    "url": "https://finnhub.io/api/news?id=e7474d8cb60223dc167841ca35343ef053bebdeb124282f3d8b4a1807ab47c3e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770987420,
      "headline": "BSX Posts Q4 Earnings: Should You Buy, Sell or Hold the Stock?",
      "id": 139085125,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific tops Q4 estimates, but shares sink on supply woes and EP losses. Can strong growth drivers fuel a 2026 rebound?",
      "url": "https://finnhub.io/api/news?id=e7474d8cb60223dc167841ca35343ef053bebdeb124282f3d8b4a1807ab47c3e"
    }
  }
]